| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $973K | +10.1% | -3.8% |
| Cost of Revenue | $447K | +30.3% | +262.4% |
| R&D Expense | $8.3M | -36.3% | +113.2% |
| SG&A Expense | $31.1M | +8.5% | +75.5% |
| Operating Income | -$57.7M | -32.5% | -143.8% |
| Interest Expense | $11.5M | +179.5% | +4551.2% |
| Pre-tax Income | -$54.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $166.1M | -87.6% | -55.4% |
| Short-term Investments | $550.4M | -11.1% | +83.0% |
| Accounts Receivable | $299K | -5.8% | +1918.9% |
| Current Assets | $1.65B | -46.7% | +141.9% |
| Total Assets | $3.27B | +0.6% | +289.8% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $2.6M | — | — |
| Capital Expenditures | $570K | — | — |
| Investing Cash Flow | -$1.97B | — | — |
| Financing Cash Flow | $2.30B | — | — |
| Free Cash Flow | $2.1M | — | — |
| -178.1% |
| -184.5% |
| Income Tax | $85K | -72.7% | — |
| Net Income | -$54.8M | -174.5% | -185.0% |
| EPS (Basic) | -$0.20 | -150.0% | -100.0% |
| EPS (Diluted) | -$0.20 | -150.0% | -100.0% |
| $38.6M |
| +65.2% |
| +168.6% |
| Long-term Debt | $950.8M | +0.7% | — |
| Total Liabilities | $987.0M | +2.3% | +4550.8% |
| Stockholders' Equity | $2.28B | -0.2% | +179.0% |